+44 117 302 1506
Select Page

RGCC Europe North and West Limited

Dr Nicola Hembry  BSc MBBS PgDip MRSB

Location

SquareWorks, 17 Berkeley Square
Bristol, BS8 1HB, United Kingdom

Get In Touch

Our head office is based in Bristol (UK) – we serve the region of North & West Europe. 

Call Us

+44 117 302 1506

Email Us

Please use the contact form at the bottom

Hours

Mon-Fri: 10am-5pm

About RGCC Europe North & West 

Dr Nicola Hembry  BSc MBBS PgDip MRSB is the Director of RGCC Europe North and West Ltd which is the Branch Office in the North and West Region of Europe for RGCC International GmbH.

RGCC lnternational GmbH has laboratories around the world which specialize  in personalized, precision medicine tests for cancer and viral illnesses, along with the manufacture of bespoke, tailored therapies for these conditions. RGCC are experts in liquid biopsy tests for circulating tumour cells (CTCs) plus associated biomarkers. Their approach reveals the genetic composition of cancers, enabling an individualised approach to therapy.

The business was launched in 2004 by genetics pioneer Dr Ioannis Papasotiriou MD PhD SCym. Dr Hembry pioneered the use of RGCC’s tests in the UK in 2005 and since 2009 has been co-director of RGCC Group’s branch office in the UK, Ireland and Scandinavia with Dr Papasotiriou.

RGCC Tests

Our cancer blood testing services, which include advanced gene and genetic analysis, are designed to deliver three key outcomes:

• Identifying potential early indicators of previously undetected cancers
• Supporting the ongoing monitoring of confirmed cancer diagnoses
• Offering tailored guidance on both standard medical therapies and complementary natural treatment options that may be suitable for each patient

Learn more about the RGCC testing options available and discover which tests best match your personal requirements by using the contact form at the bottom of the site. 

Sed Porttitor

Sed ut unde omnis iste natus error sit doloremque

Eget Tincidunt

Sed ut unde omnis iste natus error sit doloremque

Quam Vehicula

Sed ut unde omnis iste natus error sit doloremque

Elementum Aed

Sed ut unde omnis iste natus error sit doloremque

Praesent sapien

Sed ut unde omnis iste natus error sit doloremque

Vestibulum Diam

Sed ut unde omnis iste natus error sit doloremque

Sed Sit Amet

Sed ut unde omnis iste natus error sit doloremque

Nibh Pulvinar

Sed ut unde omnis iste natus error sit doloremque

Massa Convallis

Sed ut unde omnis iste natus error sit doloremque

Sit amet quam

Sed ut unde omnis iste natus error sit doloremque

Mauris Blandit

Sed ut unde omnis iste natus error sit doloremque

Vestibulum AC

Sed ut unde omnis iste natus error sit doloremque

Pellentesque

Sed ut unde omnis iste natus error sit doloremque

Vehicula Elementum

Sed ut unde omnis iste natus error sit doloremque

Vestibulum AC

Sed ut unde omnis iste natus error sit doloremque

Diam Sit Amet

Sed ut unde omnis iste natus error sit doloremque

More about RGCC

RGCC is a specialist medical genetics company and leading expert in the field of cancer genetics, liquid biopsy and chemosensitivity tests.

We provide personalised cancer genetics tests for doctors and patients worldwide in their ISO-accredited laboratories, which are equipped with the latest technology and specialised software for data analysis.

RGCC aims to detect any potential early signs of cancer, monitor existing cancers and produce a personalised profile of chemotherapy drugs and natural treatments that could benefit individual patients.

Advantages of the RGCC Testing Methods

Early Detection

A key advantage of cancer blood tests is their ability to detect signs of cancer at an early stage of the disease. Often, certain biomarkers, such as specific proteins or changes in DNA, show up in the blood before clinical symptoms appear, earlier than they can be detected by MRI or PET. This enables early diagnosis, which in turn can improve the chances of successful treatment.

Non-Invasiveness

Compared to other diagnostic methods of cancer scanning, such as tissue biopsies, blood tests are non-invasive. This means that in many cases only a blood sample needs to be extracted to perform the RGCC tests, without the need for surgical intervention or tissue removal. This makes the test less stressful and less risky for the patient.

Monitoring Disease Progression

After a cancer diagnosis, regular blood tests can help to monitor the progression of the cancer. By analyzing specific biomarkers in the blood, it is possible to determine if the tumor is growing, if treatment is working or if there have been any recurrences. This enables doctors to adapt the treatment plan and react to changes in good time.

Monitoring Disease Progression

After a cancer diagnosis, regular blood tests can help to monitor the progression of the cancer. By analyzing specific biomarkers in the blood, it is possible to determine if the tumor is growing, if treatment is working or if there have been any recurrences. This enables doctors to adapt the treatment plan and react to changes in good time.

Screening Programs

Blood tests have the potential to be used in large-scale screening programs to detect certain types of cancer at an early stage. This could help to reduce the mortality rate from cancer by detecting and treating cancers at an early stage.

About Dr Nicola Hembry

BSc MBBS PgDip MRSB

Dr Nicola Hembry is a Medical Doctor with expertise in psychology, clinical oncology, and nutritional medicine, Dr Hembry has dedicated nearly 30 years to integrative cancer care. She has spent 24 years in environmental and nutritional medicine and in 2011 completed a postgraduate qualification in clinical oncology.

 

She pioneered RGCC cancer testing in the UK in 2005 and, as Branch Director for RGCC Europe North & West, supports advanced cancer testing services across the UK, Ireland, and Scandinavia.

Frequently Asked Questions

We answer some of the most common questions below - for any thing else please get in touch with our office.
Similique sunt in culpa qui officia.

At vero eos et accusamus et iusto odio dignissimos ducimus qui blanditiis praesentium voluptatum deleniti atque corrupti quos dolores et quas molestias excepturi sint occaecati cupiditate non provident, similique sunt in culpa qui officia deserunt mollitia animi, id est laborum et dolorum fuga.

Quas molestias excepturi sint occaecati.

At vero eos et accusamus et iusto odio dignissimos ducimus qui blanditiis praesentium voluptatum deleniti atque corrupti quos dolores et quas molestias excepturi sint occaecati cupiditate non provident, similique sunt in culpa qui officia deserunt mollitia animi, id est laborum et dolorum fuga.

Similique sunt in culpa qui officia.

At vero eos et accusamus et iusto odio dignissimos ducimus qui blanditiis praesentium voluptatum deleniti atque corrupti quos dolores et quas molestias excepturi sint occaecati cupiditate non provident, similique sunt in culpa qui officia deserunt mollitia animi, id est laborum et dolorum fuga.

Sed ut perspiciatis unde omnis iste natus error.

At vero eos et accusamus et iusto odio dignissimos ducimus qui blanditiis praesentium voluptatum deleniti atque corrupti quos dolores et quas molestias excepturi sint occaecati cupiditate non provident, similique sunt in culpa qui officia deserunt mollitia animi, id est laborum et dolorum fuga.

Similique sunt in culpa qui officia.

At vero eos et accusamus et iusto odio dignissimos ducimus qui blanditiis praesentium voluptatum deleniti atque corrupti quos dolores et quas molestias excepturi sint occaecati cupiditate non provident, similique sunt in culpa qui officia deserunt mollitia animi, id est laborum et dolorum fuga.

Contact us

Call Us

+44 117 302 1506
+44 7795 056056

Our Location

SquareWorks,
17 Berkeley Square,
Bristol,
BS8 1HB,
United Kingdom

Get in touch with RGCC Europe North & West